Data from genomics, transcriptomics and known treatments of non-small-cell lung cancer (NSCLC) have been combined to produce an algorithm enabling improved treatment selection for patients with NSCLC, based on underlying individual clinical characteristics of the tumour. In total, this study included the activation status of 24 'interventional nodes' which might affect treatment responses. This intervention mapping tool will be used by the WIN Consortium to conduct a prospective clinical trial in patients with metastatic NSCLC.
References
Lazar, V. et al. A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer. Oncotarget 3 April 2015 [Epub ahead of print] http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=3741
Rights and permissions
About this article
Cite this article
Intervention mapping for NSCLC treatment selection. Nat Rev Clin Oncol 12, 374 (2015). https://doi.org/10.1038/nrclinonc.2015.83
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2015.83